Summary : Novartis has signed an initial agreement with Carisma Therapeutics, a biopharmaceutical pioneer in engineered macrophage-based therapeutics, to manufacture the HER…
Business
-
-
Lupin PharmaRegulatoryU.S FDA
Lupin launches Sevelamer Hydrochloride tablets in the United States used in treatment of kidney disease
by adminby adminHighligts : Sevelamer Hydrochloride Tablets, 800 mg is a generic equivalent of Renagel Tablets, 800 mg of Genzyme Corporation used in the…
-
RegulatoryU.S FDA
GC Pharma Receives Complete Response Letter From the U.S. FDA For ‘ALYGLO’
by adminby adminSummary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug…
-
CompaniesGlobal MarketNovartis
Syncona announces sale of portfolio company to Novartis
by adminby adminSynopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale…
-
CompaniesGskPharma Science & Research
GSK’s Bad Week: Maternal RSV Vaccine Paused, Trade Secrets Violation Alleged
by adminby adminSynopsis: GlaxoSmithKline has voluntarily paused activities in its Phase III GRACE trial on an experimental maternal vaccine for respiratory syncytial virus (RSV).…
-
Agrochemicals
Vedanta ties up with iPhone maker Foxconn to make semiconductors in India
by adminby adminSummary : Taiwan’s Foxconn on Monday said it has partnered with Indian conglomerate Vedanta Ltd to manufacture semiconductors in the South Asian…
-
-
India
Centre Approves Formation of 40 FPOs in the Bamboo Sector to Encourage Small Farmers
by adminby adminSynopsis : The Centre has approved the formation of 40 FPOs (farmer producer organizations) in the bamboo sector to encourage small and…
-
Lupin Pharma
Lupin partners Medis for distribution of NaMuscla in Central, Eastern Europe
by adminby adminSummary : Drug firm Lupin on Wednesday said it has entered into a distribution pact with Slovenia-based Medis for its orphan drug…
-
CompaniesGlobal MarketNovartis
Financials Indicate Novartis’ Sandoz Division Could Be a Tough Sell
by adminby adminSynopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%,…